Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Clinical trial NCT05236764 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05236764
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia in Remission Myelodysplastic Syndromes Chronic Myeloid Leukemia Hemophagocytic Lymphohistiocytoses Primary Immunodeficiency Diseases Hemoglobinopathies Severe Aplastic Anemia Cytopenia Bone Marrow Failure Syndrome Severe Chronic Active Epstein-Barr Virus Infection

Start date: 2023-12-06
Primary completion: 2024-08-29
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.